Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • zybio
    Junior Member
    • Mar 2015
    • 1

    #1

    Cuffdiff splicing.diff output

    Dear all,

    I run cufflinks/cuffmege/cuffdiff pipeline on my data. But I have some problem on how to interpret the splicing.diff results.
    Here are some of my results:

    test_id gene_id gene locus sample_1 sample_2 status value_1 value_2 sqrt(JS) test_stat p_value q_value significant
    TSS2038 XLOC_001278 Q91YR5 chr1:164462249-164478706 g1 g2 OK 0 0 0.358701 2.93163e-09 4.59102e-10 1.52192e-06 yes
    TSS745 XLOC_000478 NP_001074727 chr1:138362954-138428088 g1 g2 OK 0 0 0.372363 6.93969e-07 1.27085e-07 0.000210643 yes
    TSS30120 XLOC_020929 Q80TA1,uc008wvi.1 chr5:30559157-30849030 g1 g2 OK 0 0 0.278089 3.08277e-06 5.95185e-07 0.00049326 yes

    I am wondering how can I find out the splice sites from the splicing.diff results. I'd like to check the significant splicing events visually on a genome browser. But The locus provided in splicing.diff seems to be the locus of the gene/transcript, from which I can't locate the position where the splicing event happens.

    Also, I am also confused about how to figure out the AS isoforms that are compared by cuffdiff. For example, if a genes has 5 splicing variant and cuffdiff perform a spilcing test on this gene. How could I identify the two isoforms that are compared by cuffdiff ?

    Thanks a lot!

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-13-2026, 12:22 PM
0 responses
17 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-11-2026, 10:35 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
32 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
50 views
0 reactions
Last Post SEQadmin2  
Working...